ACT Brief: AI Governance Lag, Site Payment Experience, and Schizophrenia Relapse Prevention

from Applied Clinical Trials · host Applied Clinical Trials

In today's ACT Brief, we examine governance inertia when AI accelerates protocol development, why payment experience is becoming a competitive differentiator for sites, and FDA approval of Caplyta for relapse prevention in schizophrenia.

Episode metadata supplied by the publisher feed · Published Apr 29, 2026

Embed this episode

Attribution link and audio player

Ready to play

ACT Brief: AI Governance Lag, Site Payment Experience, and Schizophrenia Relapse Prevention

0:00 1:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Applied Clinical Trials?

This episode is 1 minute long.

When was this Applied Clinical Trials episode published?

This episode was published on April 29, 2026.

Can I download this Applied Clinical Trials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!